An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
Clinical trial NCT07029555 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07029555
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2028-05-15
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.